Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glucofar is a dietary supplement combination of glucosamine sulfate and chondroitin sulfate developed by Farabi Pharmaceutical Company. It is primarily used to support joint health and manage symptoms of osteoarthritis. Glucosamine sulfate serves as a precursor for glycosaminoglycans and proteoglycans, which are essential components of cartilage matrix, while chondroitin sulfate provides structural integrity and resistance to compression in joints. Together, they help stimulate cartilage matrix synthesis, inhibit catabolic enzymes, and reduce inflammatory mediators in the joint space.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on glucosamine sulfate + chondroitin sulfate (Farabi Pharmaceutical).